The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Polyakova T.A.

Russian Medical Academy of Postgraduate Education, Moscow

How many patients with Creutzfeldt—Jakob disease are there in Russia?

Authors:

Polyakova T.A.

More about the authors

Read: 9994 times


To cite this article:

Polyakova TA. How many patients with Creutzfeldt—Jakob disease are there in Russia? S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(6‑2):41‑43. (In Russ.)
https://doi.org/10.17116/jnevro20171176241-43

Recommended articles:
Difficulties in life­time diagnosis of Creutzfeldt—Jakob disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):19-27

References:

  1. Chen C, Dong XP. Epidemiological characteristics of human prion diseases. Infect Dis Poverty. 2016;2;5(1):47. https://doi.org/10.1186/s40249-016-0143-8.
  2. Will RG. Epidemiology of Creutzfeldt-Jakob disease. Br Med Bull. 1993;49(4):960-970.
  3. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S. Mortality from Creutzfeldt — Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64(9):1586-1591. https://doi.org/10.1212/01.WNL.0000160117.56690.B2
  4. Urbach H, Klisch J, Wolf HK, Brechtelsbauer D, Gass S, Solymosi L. MRI in sporadic Creutzfeldt — Jakob disease: correlation with clinical and neuropathological data. Neuroradiology. 1998;40:65-70.
  5. Lee H, Rosenmann H, Chapman J, Kingsley PB, Hoffmann C, Cohen OS, Kahana E, Korczyn AD, Prohovnik I. Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. Brain. 2009;132:2680-2687. https://doi.org/10.1093/brain/awp064
  6. Gmitterová K, Heinemann U, Bodemer M, Krasnianski A, Meissner B, Kretzschmar HA, Zerr I. 14-3-3 CSF levels in sporadic Creutzfeldt — Jakob disease differ across molecular subtypes. Neurobiol Agin. 2009;30(11):1842-1850. https://doi.org/10.1016/j.neurobiolaging.2008.01.007
  7. Stoeck K, Sanchez-Juan P, Gawinecka J, Green A, Ladogana A, Pocchiari M, Sanchez-Valle R, Mitrova E, Sklaviadis T, Kulczycki J, Slivarichova D, Saiz A, Calero M, Knight R, Aguzzi A, Laplanche JL, Peoc’h K, Schelzke G, Karch A, van Duijn CM, Zerr I. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt—Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain. 2012;135(10):3051-3061. https://doi.org/10.3390/ijms12096281
  8. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie DA, Smith P, Varges D, Heinemann U., Meissner B, Roberts H, Brandel JP, Van Dujin CM, Pocchiari M, Begue P, Cras P, Will RG, Sanchez-Juan P. Updated clinical diagnostic criteria for sporadic Creutzfeldt—Jakob disease. Brain. 2009;132:2659-2668. https://doi.org/10.1093/brain/awp191
  9. Sano K, Satoh KK, Atarashi R, Takashima H, Schmitz M, Zerr I. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUI Cassay. PLoS One. 2013;8(1):54915. https://doi.org/10.1371/journal.pone.0054915

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.